From the Department of Anesthesia, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Anesthesia, Jiaxing University Affiliated Women and Children Hospital, Jiaxing, China.
Anesth Analg. 2020 Jan;130(1):187-193. doi: 10.1213/ANE.0000000000004092.
Prophylactic IV infusion of phenylephrine has been recommended to prevent hypotension during spinal anesthesia for cesarean delivery. However, the optimal infusion dose is unknown. This study aimed to determine the infusion dose of phenylephrine that would be effective in preventing hypotension in 50% (ED50) and 90% (ED90) of patients when administered as a prophylactic infusion at a fixed rate based on the individual body weight.
Eighty parturients scheduled for elective cesarean delivery were randomly allocated to receive IV infusion of prophylactic phenylephrine at 0.25, 0.375, 0.5, or 0.625 µg/kg/min (n = 20 per group) started immediately after intrathecal injection of 10 mg hyperbaric bupivacaine and 5 µg sufentanil using a combined spinal-epidural technique. An effective dose was defined by the occurrence of no hypotension (defined as a decrease in systolic blood pressure by ≥20% below baseline and to <90 mm Hg) during the interval from the initiation of spinal anesthesia to delivery of the infant. Values for ED50 and ED90 of prophylactic phenylephrine were calculated using probit analysis.
Hypotension occurred in 13/20, 8/20, 2/20, and 1/20 patients in the groups that received phenylephrine infusion at 0.25, 0.375, 0.5, or 0.625 µg/kg/min, respectively. The calculated values for ED50 and ED90 were 0.31 (95% CI, 0.24-0.36) and 0.54 (95% CI, 0.46-0.76) µg/kg/min, respectively. No difference was found in the incidence of adverse effects and neonatal outcomes among groups.
Under the conditions of this study, when phenylephrine was given as a fixed-rate prophylactic infusion during spinal anesthesia for cesarean delivery to prevent hypotension, the values for ED50 and ED90 were 0.31 (95% CI, 0.24-0.36) and 0.54 (95% CI, 0.46-0.76) µg/kg/min, respectively.
预防性静脉输注去氧肾上腺素已被推荐用于预防剖宫产脊髓麻醉期间的低血压。然而,最佳输注剂量尚不清楚。本研究旨在确定去氧肾上腺素的输注剂量,以预防 50%(ED50)和 90%(ED90)的患者在椎管内注射 10mg 布比卡因和 5μg舒芬太尼后,根据个体体重以固定速率进行预防性输注时发生低血压。
80 例择期剖宫产产妇随机分为四组,分别接受 0.25、0.375、0.5 或 0.625μg/kg/min 的去氧肾上腺素静脉输注(每组 20 例),在蛛网膜下腔注射 10mg 布比卡因和 5μg舒芬太尼后立即开始。有效剂量定义为从脊髓麻醉开始到婴儿出生期间无低血压(定义为收缩压下降≥基线的 20%且<90mmHg)的发生率。使用概率分析计算预防性去氧肾上腺素的 ED50 和 ED90 值。
接受去氧肾上腺素输注 0.25、0.375、0.5 或 0.625μg/kg/min 的患者中,分别有 13/20、8/20、2/20 和 1/20 例出现低血压。ED50 和 ED90 的计算值分别为 0.31(95%CI,0.24-0.36)和 0.54(95%CI,0.46-0.76)μg/kg/min。各组不良反应和新生儿结局发生率无差异。
在本研究条件下,在剖宫产脊髓麻醉期间以固定速率给予去氧肾上腺素预防性输注以预防低血压时,ED50 和 ED90 值分别为 0.31(95%CI,0.24-0.36)和 0.54(95%CI,0.46-0.76)μg/kg/min。